Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS),Congenital Myasthenic Syndrome

Clinical trial NCT02189720 · APPROVED_FOR_MARKETING

Trial details

NCT number: NCT02189720
Sponsor: Catalyst Pharmaceuticals, Inc.
Status: APPROVED_FOR_MARKETING
Study type: EXPANDED_ACCESS

Congenital Myasthenic Syndrome Lambert-Eaton Myasthenic Syndrome Nystagmus, Acquired

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.